Lifetime cognitive function and timing of the natural menopause
Citation Manager Formats
Make Comment
See Comments

Abstract
Background: There is evidence that ovarian steroids influence both reproductive aging and neural development.
Objective: We investigated the relationship between menopause and lifetime cognitive function in a prospective birth cohort study.
Methods: Participants were 1,572 women enrolled in the Medical Research Council National Survey of Health and Development (the British 1946 birth cohort). By age 50, 245 women were postmenopausal, 724 were pre- or perimenopausal, 288 had had a hysterectomy or bilateral oophorectomy, and 291 women had started taking hormone replacement therapy (HRT) before their menopause. The remaining 24 women, for various reasons, could not be classified into any of these groups. We investigated the association between cognitive function at ages 8, 11, 15, 26, and 43 years and menopause timing using Cox proportional hazard models, censoring for hysterectomy and bilateral oophorectomy, and initially for HRT use. The effect of including HRT use before menopause as an additional outcome was investigated using a competing risks analysis.
Results: Higher cognitive scores were associated with later menopause. The effect was strongest in childhood. This finding could not be explained by a variety of potential confounders, including early social background, physical development, education, adult social class, parity, smoking, and alcohol consumption.
Conclusions: Childhood cognitive function is related to timing of the natural menopause. Both may be influenced by ovarian steroids across the life-span.
Estimates of the median age at menopause range between 48 and 52 years.1 There is considerable variation in the timing of the menopause, and this has implications for subsequent health. Early menopause may be a marker of biological aging2 and is associated with an increased risk of bone loss and postmenopausal osteoporosis.3-5 Late menopause is associated with an increased risk of breast cancer6,7 and endometrial cancer.8 Thus it is important to understand the causes of this variation.
Accumulated evidence suggests that reproductive aging is influenced by changes in the gonadal steroidal milieu across the life-span,9 beginning in utero and continuing in adult life, during pregnancy and repeated estrus cycles. Although controversy surrounds the extent to which events leading to menopause are under neural control,10 these steroids have a range of targets in the CNS. These include monoamine and neuropeptide systems in the brainstem and hypothalamic-pituitary axis and cholinergic projections from the basal forebrain to the cerebral cortex and hippocampus.9,11 The latter system is of central importance for cognitive function.12 It is therefore plausible that cognitive performance acts as an index of reproductive aging, and thus a predictor of menopause timing, either by covarying with gonadal steroidal levels or with central neurotransmitter changes, or both.
Little is known about the relationship between cognitive function and natural menopause timing. High adolescent IQ in the Wisconsin Longitudinal Study was associated with later menopause, after adjusting for education, occupational social class, and other variables.13 The Medical Research Council National Survey of Health and Development (NSHD) provides an opportunity to investigate this association further. This is a prospective cohort study that has followed a representative sample of the UK general population since their birth in 1946. The study has collected a wide range of medical, psychological, and demographic measures; is currently tracking timing of the menopause by annual postal questionnaire,14,15 so far until 50 years; and has measured cognitive function several times in childhood and adult life, beginning at age 8 years and most recently at age 43 years. For the majority of women this measurement preceded the age of menopausal change. We were therefore able to investigate the association between cognitive function at several ages across the life-span and timing of the menopause, taking into account a range of demographic, developmental, and behavioral potential confounders.
Methods.
The Medical Research Council National Survey of Health and Development.
The NSHD is a socially stratified birth cohort of 2,548 women and 2,814 men, followed 19 times between their birth during 1 week of March 1946 and the age of 43 years.16,17 At the last home visit, at age 43 years, the population interviewed was representative, in comparison with census data, of the British population of that age in most respects,18 although cohort members were more likely to be married and to have a nonmanual occupation.
In 1993 when the members of the cohort were age 47, a postal questionnaire concerning health during the climacteric was sent to 1,778 women study members with whom there was still contact, and an annual follow-up questionnaire has been sent since then.14 This represents 70% of the original female cohort; 6% of the original total of women in the cohort had died (n = 154), 9% were living abroad (n = 232) and were not in contact with the study, 12% had refused to participate in earlier follow-ups (n = 296), and 3% could not be traced (n = 88). This paper uses data collected between 1993 and 1996 on 1,572 women who completed at least one of the questionnaires (88%); 1,197 (67%) completed all four questionnaires.
Timing of menopause.
Information regarding the date of the last menstrual period was collected on each of the four questionnaires. Date of natural menopause was defined retrospectively after 12 months of amenorrhea. At the last contact, 245 of the 1,572 women (15.6%) were postmenopausal, and 724 (46.1%) were still premenopausal or perimenopausal. Periods had ceased for 288 women (18.3%) because of a hysterectomy or bilateral oophorectomy and for 21 women (1.4%) because of other surgical reasons (mostly endometrial ablation) or medical treatment (for example, chemotherapy). The menopausal status at the last contact could not be classified for 291 women (18.5%) who had started taking hormone replacement therapy (HRT) before the menopause, 1 who gave insufficient information, and 2 who were taking oral contraceptives.
Cognitive measures.
At ages 8, 11, 15, and 26 years study members took tests of verbal and nonverbal ability devised by the National Foundation for Educational Research.19,20 Tests were as follows: age 8—reading comprehension (sentence completion), pronunciation, vocabulary, and nonverbal reasoning; age 11—verbal and nonverbal intelligence (series completion), arithmetic (addition, multiplication, subtraction, and division), pronunciation (as at age 8), and vocabulary (as at age 8); age 15—Group Ability Test AH4 (verbal and nonverbal intelligence), Watts-Vernon Reading Test (sentence completion), and mathematics (arithmetic, geometry, trigonometry, and algebra); age 26—Watts-Vernon Reading Test (as given at age 15, with an additional 10 items of increased difficulty to avoid a ceiling effect). Because the content and number of intelligence tests at 8, 11, 15, and 26 years varied according to age, standardized scores were derived so that the strength of the association between cognitive function at different ages and timing of the menopause could be compared. Each test score was standardized to give a mean of 0 and a standard deviation (SD) of 1, using the total sample with a valid score for each test. Scores representing overall cognitive function in childhood, adolescence, and early adult life were obtained by averaging the individual standardized scores at ages 8, 11, 15, and 26.
At age 43 four tests devised by the NSHD were administered by a trained research nurse during a home visit: 1) Verbal memory (15-word list learning task, with three learning trials). The sum of three trials was taken to give a score out of a maximum of 45. 2) Visual memory (5-item delayed free recall task). 3) Timed visual search task (target letters P and W). The average from three trials was used to derive a speed score (total number of letters scanned in 1 minute) and an accuracy score (number of target letters correctly identified minus targets missed). 4) Timed manual peg placement. The average time, in seconds, to complete this test was based on 10 trials (5 with the right hand and 5 with the left).
Potential confounders.
Potential confounders that might affect the relationship between cognitive function and timing of the menopause were identified from previous research and from preliminary analyses. Potential confounders in childhood were measures of family background (assessed by measures of paternal social class, maternal education, birth order, and maternal age at birth of the participant) and developmental characteristics (birth weight, age at reaching developmental milestones, childhood height and weight, and age at menarche). Paternal social class was assigned using the father’s occupation (classified as professional, managerial, intermediate, skilled manual, semi-skilled manual, and unskilled) when the participant was age 11 years or, if this was unknown, occupation at 4 or 15 years.21 Maternal education was classified into those with primary or secondary education only with no formal qualifications and those with formal qualifications or any further education. Developmental milestones were taken as the age at first sitting up, standing, walking, and talking (use of language beyond “mum,” “dad,” or “nan”), reported when respondents were age 2 years. Age at menarche was based on mothers’ reports when participants were age 15 years, coded as months since birth.
Potential adult confounders were as follows: socioeconomic status (assessed by the social class of the head of the household at 43 years or earlier if this was unavailable, using similar categories to those for paternal occupational social class), own educational attainment (see below), premenopausal body mass index (measured at 36 years), parity, oral contraceptive use at age 43 years or earlier, anxiety and depression at age 43 measured by the Psychiatric Symptom Frequency scale,22 having ever smoked at least one cigarette per day for at least 1 year up to age 43,23 and potential alcohol abuse at age 43,24 represented by at least two positive items on the CAGE screen25 applied to the preceding 12 months.
The highest educational or training qualification achieved by 26 years was classified by the Burnham scale26 and grouped as follows: no qualification, below ordinary secondary qualifications, ordinary secondary qualifications (“O” levels and their training equivalents), advanced secondary education (“A” levels and their equivalents), or higher education (degree level or equivalent).
Statistical methods.
Age at natural menopause, in months from birth, provided the outcome of interest. For women who only gave an age to the nearest year (n = 62), the midpoint of that year was used. This assumption was checked using a sensitivity analysis, but the results were hardly altered and so are not presented here.
Kaplan-Meier estimates of the survivor function27 were produced and plotted to compare survival distributions, with survival being the time until menopause, for three groups of women. Three groups were used to ensure clarity of the plots, and women were allocated to one of the three groups based on their cognitive score, whereby two cut points of the cognitive score distribution were defined so that approximately equal-sized groups were obtained. Log-rank tests28 were performed to test formally the differences in survival between the three different groups.
Cox proportional hazard models29 were used to investigate the combined effects of cognitive scores across the life course. Initially each cognitive score from ages 8 to 26 was entered into the model separately and the linearity of the relationship with the log hazard ratio assessed using a likelihood ratio test to determine whether a quadratic term improved the fit of the model. A hazard ratio for an increase in one standardized unit of each score was thus obtained. Women were categorized into four approximately equal-sized groups based on three cut points of the distribution of measures of cognitive function at age 43 years. This categorization was carried out because the tests related to different types of measures of cognitive function, and were measured in different units, and because the distribution of some of the test scores was highly skewed. Each test score was then fitted either as a categorical factor with four levels or as a linear effect, with the levels of cognitive score coded from lowest to highest as 0, 1, 2, and 3. The latter coding was used if the linear effect was significant at the 10% level and there was no departure from linearity, as indicated by the likelihood ratio test comparing the models with the different parameterizations.30 Starting with the earliest cognitive score associated with age at menopause and working forward in time, a model including all scores independently associated with age at menopause was derived, with the improvement in fit due to the addition of each new cognitive score assessed using a likelihood ratio test. The earliest cognitive score was used as the starting point to assess how far back in the life course any such association may be detected. This model was further adjusted for each of the potential confounders in turn to see whether any of these attenuated the effects of the cognitive tests. The final analyses adjusted firstly for all childhood confounders, to assess whether other early life factors had an impact on the effect of cognition, and secondly for all the adult factors to assess whether any relationship with cognition was due to other risk behaviors being related to cognitive function.
In these analyses, women who had undergone hysterectomy or bilateral oophorectomy before menopause were censored at the age at which the operation took place. Women who were premenopausal or perimenopausal at their last contact were censored at the date they completed the last questionnaire. Women who started taking HRT before the menopause were censored at the date of starting HRT. The small number of women whose periods stopped for other reasons, such as surgery or medical treatment (n = 21) and those who were using oral contraceptives (n = 2) were omitted from the analyses. Also omitted were women who had given insufficient information to assess menopausal status (n = 1) or attribute a date for menopause (n = 7) or for starting HRT (n = 2).
A significant number of women who commenced HRT before their periods ceased for at least 12 months may have been approaching menopause, and therefore the assumption of independence between outcome and censoring would not hold. Further analyses using a competing risks framework31,32 were therefore carried out to assess the possible influence of the HRT users on the results. First, age at either menopause or start of HRT use was taken as the outcome, using whichever event came earlier. Then age at starting HRT was used as the outcome, censoring those who reached natural menopause at the date of this event. As in the main analyses, women who had undergone hysterectomy were censored, as were those who were still premenopausal or perimenopausal at the last contact.
The assumption of proportional hazards made in the Cox model was checked by including a time-dependent covariate in the model and using a likelihood ratio test to assess the improvement in fit due to that term. All analyses were performed using the statistical computer software SAS.33
Results.
Cox proportional hazards models, with standardized cognitive test scores at ages 8, 11, 15, and 26 years included in turn indicated that the higher the cognitive score at age 8, the later the age at menopause. There was no evidence against the proportional hazards assumptions. The p value related to each of these scores increased because of, at least in part, decreased sample size when considering the restricted population of women who have a complete record of test scores (table 1), although the point estimates are hardly changed. The verbal memory (word list) test score and the accuracy score of the timed visual search task at age 43 years showed associations with age at menopause (see table 1). As with the earlier cognitive scores, the better the cognitive performance, the later the menopause. There was no evidence of an association between any of the other three test scores at 43 years and age at menopause.
Results from Cox proportional hazard models considering the effect of each cognitive test score on age at menopause
A Kaplan-Meier survival plot for time to menopause for women scoring in each third of the distribution of cognitive score at age 8 years (figure) shows that women with a low cognitive performance at age 8 tended to reach menopause earlier than other women (log-rank test, p = 0.003). By the time the members of the cohort were age 46 years, 5% of women scoring in the lowest third of the cognition score had reached menopause compared with 3% of women in the highest third. By age 50 years, 26% of women scoring in the lowest third of the cognition score had reached menopause, compared with 16% in the highest third. Women in the lowest third of the cognition score had a mean raw score of 59.89 (SD = 14.51) of a possible total of 195 compared with those in the middle third (mean 91.80 [SD 7.14]) and highest third (mean 120.28 [SD = 12.94]). The Kaplan-Meier plot also indicates that the lines representing the middle and high scoring groups cross, which may suggest that the proportional hazards assumption is violated when this categorical variable is considered.
Figure. Survivor functions for age at menopause by thirds of cognitive score at 8 years of age.
The effect of cognition was strongest at ages 8 and 11 years in the sample of women with a complete record of test scores (see table 1), and no departures from a linear relationship between cognitive score and the log hazard ratio were found. The cognition score at the earliest age was therefore included in a model and each subsequent score added (table 2). Only women with valid records for each pair of tests were included in these models. For comparison purposes the results from the unadjusted models for each score are shown for each restricted population (see table 2).
Results from Cox proportional hazard models considering the effect of each cognitive test score, adjusted for cognitive score at age 8, on age at menopause
The model including scores at ages 8 and 11 showed a reduction in the effects of both scores (see table 2), suggesting colinearity. There were no independent effects of the 15-, 26-, or 43-year scores. Once the 8-year score was included, none of the other scores further improved the fit of the model. The effect of cognition at age 8 years was not modified by any of the potential confounders considered when they were entered separately, one at a time, into the model. The models adjusted for the childhood factors and the adult factors resulted in a reduction in sample size, with 809 women included in the childhood model and 1,038 in the adult model. The estimated hazard ratio and 95% confidence interval (CI) for the model adjusted for all childhood confounders was 0.72 (0.56, 0.92) and that adjusted for all adult confounders 0.70 (0.55, 0.90).
The analysis with either menopause or HRT use as the outcome indicated that the unadjusted effect was still significant at the 5% level, although the estimated hazard ratio was closer to 1 (hazard ratio [95% CI] = 0.84 [0.76, 0.94]). Adjustment for all childhood confounders produced a hazard ratio of 0.86 (0.74, 1.02) and for all adult confounders one of 0.86 (0.73, 1.01). These findings are due to a lack of an association between cognitive score at age 8 years and age at start of HRT use (unadjusted hazard ratio = 0.95 [0.82, 1.10]).
Women excluded from the analysis (n = 201) of the association between cognitive score at age 8 years and age at menopause because of missing data had the same risk of reaching menopause at each age as those included in the analysis. They did, however, perform below average on the cognitive tests at ages 11 and 15 years compared with women included in the analysis. They were also more likely to have come from a nonmanual social class in childhood and have a mother with educational qualifications. Furthermore, women who had a missing cognitive test score at one age scored lower on average in all previous tests compared with those who had a valid test score.
Discussion.
In a large representative British cohort born in the immediate post-war era, cognitive function at ages 8 and 11 years was strongly associated with timing of the natural menopause, with high ability associated with later menopause. Weaker associations found between timing of the menopause and similar measures of cognitive function at ages 15 and 26 years were further attenuated after adjustment for cognitive function at age 8 years. Qualitatively different cognitive tests at age 43 years failed to show any consistent relationship with the timing of menopause, although associations with the verbal memory test and the accuracy score of the timed visual search task were observed and showed trends in the expected direction. These trends were, however, greatly attenuated after adjustment for childhood cognitive function. Although these results support findings from the Wisconsin Longitudinal Study, where high adolescent IQ was associated with later menopause,13 our study shows that the effect of cognitive function can be traced further back in childhood. Importantly, the tests given during childhood and adolescence were essentially those of intelligence (verbal and nonverbal ability) rather than representing a broad range of cognitive function. We do not know, therefore, whether the association between cognitive function and menopause timing might be stronger in some cognitive domains than in others.
The associations between childhood cognitive function and timing of the menopause in the present study were not confounded by measures of sociodemographic background or physical development, nor by a range of adult factors, including educational and occupational attainment, body mass index, parity, anxiety and depression, smoking, and possible alcohol abuse. That the association between cognitive function and timing of the menopause can be explained by the former acting as a proxy for socioeconomic status and its consequences for health and development is therefore unlikely.
Although the sample included in each of the analyses may have had a higher average cognitive function than the total sample, there is no reason to suspect that this would have had a major impact on the results.
A greater proportion of women in this younger cohort were taking HRT compared with most previous studies using older cohorts, where the users are usually excluded from analysis. Increased popularity of HRT will continue to present methodologic problems in epidemiologic studies of natural menopause timing. Specifically, the analysis with age at menopause as the outcome and HRT users as censored observations does not necessarily provide a valid estimate of the relationship between cognitive score and age at menopause in a population in which HRT use is absent. Such an interpretation is only possible if menopause and first use of HRT are independent events. However, a lack of independence is suggested by evidence that start of HRT use is associated with symptoms related to the perimenopause.34-36 The interpretation of the relationship between cognitive score and age at menopause would then be restricted to conditions prevalent in the study, and so may not be generalizable to populations with different patterns of HRT use. The analysis for age at first event (either menopause or HRT use) could be considered as a sensitivity analysis to the extreme assumption that age at start of HRT use is a surrogate measure for age at menopause. The estimate of the effect of cognition is weaker in such an analysis but is still significant at the 5% level.
How may the present finding of an association between childhood cognitive function and menopause timing be interpreted? To the extent that timing of the menopause is determined by exhaustion of ovarian follicles, two critical factors are the number of primordial follicles laid down during ontogeny and the events that regulate depletion of this stockpile.10 Little is known about factors that determine the initial follicular endowment, although poor growth and development in late gestation may play a role.37 However, there is debate over the extent to which the depletion rate of these follicles is under neural control. One focus of this debate is the reported desynchrony of neurotransmitter rhythms in the hypothalamus during aging, which may play an important role in triggering the cascade of events leading to menopause.10 Yet the present study identifies a CNS-related predictor of menopause timing emerging at least as early as prepubescent childhood. This is consistent with studies showing the influence of early gonadal hormone exposure on CNS development.38 Of particular relevance to the present results is the effect of early gonadal hormonal exposure on learning behavior in rats.39,40 Estrogen also has a trophic effect on cholinergic projections from the basal forebrain to the cerebral cortex and hippocampus,12 brain regions of central importance for cognitive function. Corroborative evidence in humans comes from studies of HRT, which facilitates verbal memory41 and protects against symptoms of dementia.42 Cognitive function may therefore provide a crude index of ovarian steroidal influence on the CNS and the effects of this association on reproductive aging.
We plan to repeat cognitive testing at age 53 years, when most of these women will be postmenopausal. This will help to determine whether women who come early to menopause are at risk for functionally significant cognitive decline. If so, these results would suggest that causal factors are in place long before onset of the climacteric.
Acknowledgments
Supported by the UK Medical Research Council.
Acknowledgment
The authors are grateful to Professor Howard Jacobs, Endocrine Unit, University College London Medical School, for kind and valuable advice during the preparation of this manuscript.
- Received July 18, 1998.
- Accepted February 19, 1999.
References
- ↵
Sowers M-FR, LaPietra MT. Menopause : its epidemiology and potential association with chronic diseases. Epidemiol Rev 1995;17:287–302.
- ↵
- ↵
- ↵
- ↵
Trichopoulos D, MacMahon B, Cole P. Menopause and breast cancer. J Natl Cancer Inst 1972;48:605–613.
- ↵
Henderson BE, Powell D, Rosaria I, et al. An epidemiologic study of breast cancer. J Natl Cancer Inst 1974;53:609–614.
- ↵
Kelsey JL, LiVolsi VA, Holford TR, et al. A case-control study of cancer of the endometrium. Am J Epidemiol 1982;116:333–342.
- ↵
vom Saal FS, Finch CE, Nelson JF. Natural history and mechanisms of reproductive aging in humans, laboratory rodents, and other selected vertebrates. In: Knobil E, Neill JD, eds. The physiology of reproduction. 2nd ed. New York:Raven Press, 1994:1213–1314.
- ↵
Wise PM, Krajnak KM, Kashon ML. Menopause : the aging of multiple pacemakers. Science 1996;273:67–70.
- ↵
- ↵
Kopelman MD. The cholinergic neurotransmitter system in human memory and dementia : a review. Q J Exp Psychol 1986;38A:535–573.
- ↵
Shinberg DS. An event history analysis of age at last menstrual period : correlates of natural and surgical menopause among midlife Wisconsin women. Soc Sci Med 1998;46:1381–1396.
- ↵
- ↵
Hardy R, Kuh D. Reproductive characteristics and the age at inception of the perimenopause in a British national cohort. Am J Epidemiol 1999;149:612–620.
- ↵
Wadsworth MEJ. The imprint of time: childhood, history and adult life. Oxford:Martin Robertson, 1991.
- ↵
- ↵
Wadsworth MEJ, Mann SL, Rodgers B, Kuh DL, Hilder WS, Yusuf EJ. Loss and representativeness in a 43 year follow-up of a national birth cohort. J Epidemiol Community Health 1992;46:300–304.
- ↵
Pigeon DA. Tests used in the 1954 and 1957 surveys. In: Douglas JWB, ed. The home and the school. London: Macgibbon & Kee, 1964: Appendix 1.
- ↵
Pigeon DA. Detail of the fifteen years tests. In: Douglas JWB, Ross JM, Simpson HR, eds. All our future. London: Davies, 1968: Appendix 1.
- ↵
Office of Population Censuses and Surveys.Classification of occupations. London:HMSO, 1970.
- ↵
- ↵
- ↵
- ↵
- ↵
Department of Education and Science.Burnham further education committee grading courses. London:HMSO, 1972.
- ↵
- ↵
Mantel N. Evaluation of survival data and two rank order statistics arising in its consideration. Cancer Chemotherapy Reports 1966;50:163–170.
- ↵
Cox DR. Regression models and life tables (with discussion). J R Stat Soc, B 1972;74:187–220.
- ↵
Clayton D, Hills M. Statistical models in epidemiology. Oxford:Oxford University Press, 1993.
- ↵
- ↵
Farewell VT. An application of Cox’s proportional hazard model to multiple infection data. J R Stat Soc C 1979;28:136–143.
- ↵
SAS Institute Inc.SAS user’s guide: statistics, version 5 edition. Cary, NC:SAS Institute Inc, 1985.
- ↵
Greenberg G, Thompson SG, Meade TW. Relation between cigarette smoking and use of hormonal replacement therapy for menopausal symptoms. J Epidemiol Community Health 1987;41:26–29.
- ↵
Johannes CB, Crawford SL, Posner JG, McKinlay SM. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am J Epidemiol 1994;40:439–452.
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease
Dr. Rizwan S. Akhtar and Dr. Sarah Brooker
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Article
Age at menopause and lifetime cognitionFindings from a British birth cohort studyDiana Kuh, Rachel Cooper, Adam Moore et al.Neurology, April 11, 2018 -
Article
Age at surgical menopause influences cognitive decline and Alzheimer pathology in older womenRiley Bove, Elizabeth Secor, Lori B. Chibnik et al.Neurology, December 11, 2013 -
Article
Reproductive period and risk of dementia in a diverse cohort of health care membersPaola Gilsanz, Catherine Lee, Maria M. Corrada et al.Neurology, March 28, 2019 -
Article
Cognitive effects of estradiol after menopauseA randomized trial of the timing hypothesisVictor W. Henderson, Jan A. St. John, Howard N. Hodis et al.Neurology, July 15, 2016